Abstract
The effects of clozapine, thioridazine, perlapine and haloperidol on the metabolism of the biogenic amines in the brain of the rat have been investigated.
Haloperidol, perlapine and thioridazine induce catalepsy and enhance the turnover of DA in the striatum, as indicated by the dose-dependent increase in the DA-metabolites, HVA and DOPAC. These effects are due to blockade of dopaminergic transmission, haloperidol being far more potent than perlapine or thioridazine. Clozapine differs from these agents in that it elevates the concentration of striatal DA. The increase of the concentrations of HVA and DOPAC by clozapine is not accompanied by development of catalepsy. Therefore, clozapine seems to influence striatal DA by a mechanism other than DA-receptor blockade.
All four drugs enhance the turnover of NA in the brain stem. This effect is probably secondary to the blockade of NA-receptors. There was no correlation between the effects on NA-metabolism and the EEG-arousal inhibitory activities of these agents or their clinical antipsychotic effects.
Clozapine increase the concentration of 5-HT and 5-HIAA in the brain. This effect was not seen with the other drugs. Perlapine seems to enhance the turnover of 5-HT, whereas haloperidol reduces the 5-HT concentration. Thioridazine appears to have no effect on the metabolism of 5-HT.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Andén, N. E., Butcher, G. S., Corrodi, H., Fuxe, K., Ungerstedt, U.: Receptor activity and turnover of dopamine and noradrenaline after neuroleptics. Europ. J. Pharmacol. 11, 303–314 (1970)
Andén, N. E., Roos, B. E., Werdenius, B.: On the occurrence of homovanillic acid in brain and cerebrospinal fluid and its determination by a fluorimetric method. Life Sci. 2, 448–458 (1963)
Angst, J., Bente, D., Berner, P., Heimann, H., Helmchen, H., Hippius, H.: Das klinische Wirkungsbild von Clozapin. Pharmakopsychiat. 4, 201–211 (1971)
Anton, A. H., Sayre, D. F.: A study of the factors affecting the aluminium oxide trihydroxyindole procedure for the analysis of catecholamines. J. Pharmacol. exp. Ther. 138, 360–375 (1962)
Anton, A. H., Sayre, D. F.: The distribution of dopamine and DOPA in various animals and a method for their determination in diverse biological material. J. Pharmacol. exp. Ther. 145, 326–336 (1964)
Asper, H., Baggiolini, M., Bürki, H. R., Lauener, H., Ruch, W., Stille, G.: Tolerance phenomena with neuroleptics. Catalepsy, apomorphine stereotypies and striatal dopamine metabolism in the rat after single and repeated administration of loxapine and haloperidol. Europ. J. Pharmacol. 22, 287–294 (1973)
Bartholini, G., Haefeli, W., Jalfre, M., Keller, H. H., Pletscher, A.: Effects of clozapine on cerebral catecholaminergic neurone systems. Brit. J. Pharmacol. 46, 736–740 (1972)
Bartholini, G., Keller, H. H., Pletscher, A.: Effect of neuroleptics on endogenous norepinephrine in rat brain. Neuropharmacology 12, 751–756 (1973)
Bobillier, P., Froment, J. L., Seguin, S., Jouvet, M.: Effects de la p-chlorophenylalanine et du 5-hydroxytryptophane sur le sommeil et le metabolisme central des monoamines et des proteines chez le chat. Biochem. Pharmacol. 22, 3077–3090 (1973)
Bürki, H. R.: Metabolismus von Dopamin und Noradrenalin im Hirn der Ratte nach akuter und chronischer Verabreichung von Haloperidol, Loxapin und Clozapin. Symposium der Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP), Nürnberg, Oktober 1973.
Bürki, H. R., Ruch, W., Asper, H., Baggiolini, M., Stille, G.: Pharmakologische und neurochemische Wirkungen von Clozapin: neue Gesichtspunkte in der medikamentösen Behandlung der Schizophrenie. Schweiz. med. Wschr. 103, 1716–1724 (1973)
Bürki, H. R., Ruch, W., Asper, H., Baggiolini, M., Stille, G.: Effect of single and repeated administration of clozapine on the metabolism of dopamine and noradrenaline in the brain of the rat. Europ. J. Pharmacol. 27, 180–190 (1974)
Carlsson, A., Lindqvist, M.: Effect of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain. Acta pharmacol. (Kbh.) 20, 140–144 (1963)
Carlsson, A., Lindqvist, M. Fuxe, K., Hökfelt, T.: Histochemical and biochemical effects of diethyldithiocarbamate on tissue catecholamines. J. Pharm. Pharmacol. 18, 60–62 (1966)
Euler, U. S. von, Lishajko, F.: Improved technique for the fluorimetric estimation of catecholamines. Acta physiol. scand. 51, 348–356 (1961)
Gey, K. F., Pletscher, A.: Acceleration of turnover of 14C-catecholamines in rat brain by chlorpromazine. Experientia (Basel) 24, 335–336 (1968)
Giacalone, E., Valzelli, L.: A spectrofluorometric method for the simultaneous determination of 2-(5-hydroxyin-dol-3-yl) ethylamine (serotonin) and 5-hydroxyindol3-yl-acetic acid in the brain. Pharmacology 2, 171–175 (1969)
Gitlow, S. E., Warner, R. R. P., Bertani, L. M.: Catecholamines and indolamines in human disease. In: Methods in investigative and diagnostic endocrinology. Berson, S.A., ed., Vol. 1, pp. 641–669. Amsterdam: North-Holland 1972
Jones, B. E., Bobillier, P., Pin, C., Jouvet, M.: The effect of lesions of catecholamine-containing neurons upon monoamine content of the brain and EEG and behavioral waking in the cat. Brain Res. 58, 157–177 (1973)
Keller, H. H., Bartholini, G., Pletscher, A.: Increase of 3-methoxy-4-hydroxyphenylethyleneglycol in rat brain by neuroleptic drugs. Europ. J. Pharmacol. 23, 183–186 (1973)
MØller-Nielsen, I., FjÄlland, B., Pedersen, V., Nymark, M.: Pharmacology of neuroleptics upon repeated administration. Psychopharmacologia (Berl.), 34, 95–104 (1974)
NybÄck, H., Sedvall, G.: Further studies on the accumulation and disappearance of catecholamines formed from tyrosine-14C in mouse brain. Effect of some phenothiazine analogues. Europ. J. Pharmacol. 10, 193–205 (1970)
Peters, D. A. V.: Inhibition of serotonin biosynthesis by 6-halotryptophans in vivo. Biochem. Pharmacol. 20, 1413–1420 (1971)
Sayers, A. C., Bürki, H. R., Ruch,W., Asper, H.: Hypersensitivity of striatal dopamine receptors in the rat. A method for predicting the occurrence of tardive dyskinesias after antipsychotic drugs? IXème Congrès du C.I.N.P., Paris, July 1974
Sayers, A. C., Kleinlogel, K.: Neuropharmakologische Befunde unter chronischer Verabreichung von Haloperidol, Loxapin und Clozapin. Symposium der Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP), Nürnberg, Oktober 1973
Schelkunov, E. L.: Adrenergic effect of chronic administration of neuroleptics. Nature (Lond.) 214, 1210–1212 (1967)
Schubert, J.: Metabolism of 5-hydroxytryptamine in brain and the effect of psychoactive drugs. Ph. D. thesis, Departments of psychiatry and pharmacology, Karolinska Institutet, Stockholm 1973
Sedval, G., NybÄck, H.: Effect of clozapine and some other antipsychotic agents on synthesis and turnover of dopamine formed from 14C-tyrosine in mouse brain. Joint E.B.B.S.-I.C.F.P.B. Workshop Meeting, Jerusalem 1972
Spano, P. F., Neff, N. H.: Procedure for the simultaneous determination of dopamine, 3-methoxy-4-hydroxyphenylacetic acid, and 3,4-dihydroxyphenylacetic acid in brain. Analyt. Biochem. 42, 113–118 (1971)
Stille, G.: Neurophysiological substrates of the pharmacological criteria for neuroleptics. In: Modern problems of pharmacopsychiatry, The neuroleptics. Bobon, D. P., Janssen, P. A.J., and Bobon, J., eds., Vol.5, pp. 56–60. Basel-München-Paris-New York: Karger 1970
Stille, G., Hippius, H.: Kritische Stellungnahme zum Begriff der Neuroleptika (anhand von pharmakologischen und klinischen Befunden mit Clozapin). Pharmakopsychiat. 4, 182–191 (1971)
Stille, G., Lauener, H., Eichenberger, E.: The pharmacology of 8-chloro-11-(4-methyl-1-piperazinyl)-5h-di-benzo[b,e] [1,4]diazepine (clozapine). Farmaco 26, 603–625 (1971)
Stille, G., Sayers, A. C., Lauener, H., Eichenberger, E.: 6-(4-Methyl-1-piperazinyl)-morphanthridine (perlapine), a new tricyclic compound with sedative and sleep-promoting properties. Psychopharmacologia (Berl.) 28, 325–337 (1973)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bürki, H.R., Ruch, W. & Asper, H. Effects of clozapine, thioridazine, perlapine and haloperidol on the metabolism of the biogenic amines in the brain of the rat. Psychopharmacologia 41, 27–33 (1975). https://doi.org/10.1007/BF00421302
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00421302